Immune Checkpoint Inhibitors in Cancer

Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It's an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.

• Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages.

• Helps you translate current research and literature into practical information for daily practice.

• Presents information logically organized by disease site.

• Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks.

• Consolidates today's available information on this timely topic into one convenient resource.

  Autorentext
  Dr. Fumito Ito is Associate Professor of Oncology, Department of Surgical Oncology and a member of the Center for Immunotherapy at Roswell Park Cancer Institute, as well as Associate Professor of Surgery at Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York.

  Inhalt

  1. Tumor Immunology*
• 2. Melanoma and Other Skin Cancers*
• 3. Thoracic Malignancies*
• 4. Gastrointestinal, Hepatobiliary, and Pancreatic Malignancies*
• 5. Cancers of the Head and Neck*
• 6. Urologic Malignancies*
• 7. Gynecologic Malignancies*
• 8. Breast Cancer*
• 9. Hematologic Malignancies*
• 10. Pediatric Malignancies*
• 11. Toxicities Associated with Immune Checkpoint Inhibitors*
• 12. Future of Immune Checkpoint Inhibitors